This poster highlights the development, characterization and application of Ncyte® NHP-C vCardiomyocytes, addressing a critical translational gap in nonclinical safety pharmacology.
Download it now for an exclusive look at:
- Why NHP-derived cardiomyocytes are needed to improve cross-species translation in cardiac safety testing
- How Ncardia’s proprietary 3D bioreactor and robust assay platforms ensure reproducibility, scalability, and predictive power
- Data highlights including flow cytometry, MEA and impedance assays and comparative pharmacology tests
Download the Poster